Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01593319|
Recruitment Status : Terminated
First Posted : May 8, 2012
Last Update Posted : April 21, 2015
The main hypothesis of the study is that anaesthesia of the hip using infiltration with a local anesthetic solution is preferable over traditional analgesia with oral opioid medications in the acute stage of the management of patients with a fracture of the hip.
To study the hypothesis the investigators designed a prospective randomised study where patients are assigned in two groups, the first receiving local hip anesthesia and the other placebo treatment. Both groups are eligible to use of standard oral pain treatment.
Effect of analgesia as well as medical complications will be recorded.
|Condition or disease||Intervention/treatment||Phase|
|Hip Fractures||Drug: Ropivacaine Drug: Natrium chloride||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||37 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Study Start Date :||January 2012|
|Actual Primary Completion Date :||April 2015|
|Actual Study Completion Date :||April 2015|
|Active Comparator: ropivacaine||
Local injection (fascia iliaca block) using 150 mg ropivacaine
Other Name: Narop
|Placebo Comparator: Natrium chloride||
Drug: Natrium chloride
Placebo injection of Natrium chloride solution
- Pain [ Time Frame: 3 hours ]
- medical complications (Number of participants that develop pressure ulcers, number of participants that develop pneumonia) [ Time Frame: under hospitalization (expected average of 10 days) ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01593319
|Ortopedkliniken, Centralsjukhuset i Karlstad|
|Karlstad, Värmland, Sweden, S-65185|
|Study Chair:||Anders Hallberg, Forskningsschef||Centrum för klinisk forskning. Centralsjukhuset, 651 85 Karlstad, Sweden|